Table 2.
ACB score 1 (% of patients with prescription) | ||||
---|---|---|---|---|
All (N = 378.716) | Older adults (N = 148.706) | Adults (N = 180.413) | Children (N = 49.597) | |
loratadine | 26.3 | 11.8 | 26.1 | 70.8 |
alprazolam | 17.1 | 19.7 | 19.5 | 0.3 |
furosemide | 14.6 | 32.0 | 4.3 | <1.0 |
desloratadine | 11.9 | 4.7 | 17.4 | 14.1 |
warfarin | 7.2 | 16.2 | 1.9 | <1.0 |
diazepam | 7.0 | 7.2 | 8.4 | <1.0 |
ranitidine | 7.0 | 7.2 | 8.4 | <1.0 |
cetirizine | 6.6 | 3.8 | 7.7 | 11.3 |
metoprolol | 3.7 | 6.9 | 2.1 | <1.0 |
risperidone | 3.2 | 4.5 | 2.5 | 1.6 |
levocetirizine | 3.0 | <1.0 | 4.2 | 3.8 |
nifedipine | 2.9 | 5.4 | 1.7 | <1.0 |
trazodone | 3.0 | 2.8 | 4.1 | <1.0 |
venlafaxine | 2.0 | 1.4 | 3.0 | <1.0 |
isosorbide mononitrate | 2.0 | 4.8 | <1.0 | <1.0 |
bupropion | <1.0 | <1.0 | 2.2 | <1.0 |
aripiprazole | <1.0 | <1.0 | 1.7 | <1.0 |
haloperidol | <1.0 | 1.9 | <1.0 | <1.0 |
fentanyl | <1.0 | 2.3 | <1.0 | <1.0 |
captopril | <1.0 | 2.0 | <1.0 | <1.0 |
ACB score 2 (% of patients with prescription) | ||||
All (N = 8.109) | Older adults (N = 3.095) | Adults (N = 4.694) | Children (N = 320) | |
carbamazepine | 72.4 | 74.9 | 73.3 | 36.3 |
oxcarbazepine | 14.9 | 11.0 | 14.1 | 64.4 |
levomepromazine | 8.8 | 7.5 | 10.4 | 0 |
amantadine | 5.3 | 7.5 | 4.2 | 0 |
ACB score 3 (% of patients with prescription) | ||||
All (N = 105.585) | Older adults (N = 43.901) | Adults (N = 58.837) | Children (N = 2.847) | |
quetiapine | 31.5 | 41.2 | 25.3 | 8.4 |
trospium | 31.0 | 21.2 | 38.0 | 39.8 |
paroxetine | 13.5 | 10.2 | 16.6 | 1.3 |
olanzapine | 8.6 | 6.0 | 10.8 | 3.7 |
solifenacin | 6.1 | 9.3 | 3.9 | 0.3 |
amitriptyline | 4.9 | 4.7 | 5.2 | 0.6 |
tamsulosin and solifenacin | 4.6 | 7.4 | 2.7 | 0 |
atropine | 2.7 | 1.8 | 1.5 | 42.8 |
clozapine | 2.6 | 1.6 | 3.6 | 0.1 |
fesoterodine | 1.6 | 1.3 | 0.6 | 0.2 |
darifenacin | 1.5 | 2.6 | 0.8 | 0 |
tolterodine | 0.7 | 0.9 | 0.3 | 4.1 |
scopolamine | <0.1 | <0.1 | <0.1 | 0 |
*Numbers in bold represent prevalence above 5%.
Of note: Each patient may have received prescriptions for two medications with mild anticholinergic burden in 2018, eg. loratadine and alprazolam, and therefore appeared in the calculation twice. Hence, the percentage sum in each category may be higher than 100.